| Helen A Farrah-mcgrail, LISW | |
|
3194 Core Rd, Parkersburg, WV 26104-1556 | |
| (304) 485-5185 | |
| (304) 485-0051 |
| Full Name | Helen A Farrah-mcgrail |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 3194 Core Rd, Parkersburg, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538206479 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | I.0010237 (Ohio) | Secondary |
| 1041C0700X | Social Worker - Clinical | DP00945247 (West Virginia) | Primary |
| Entity Name | Hopewell Health Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699010348 PECOS PAC ID: 9234049990 Enrollment ID: O20110209000712 |
News Archive
Clinicians testing the drug dasatinib, approved for several blood cancers, had hoped it would slow the aggressive growth of the deadly brain cancer glioblastoma; however, clinical trials to date have not found any benefit. Researchers at Mayo Clinic, who conducted one of those clinical trials, believe they know why dasatinib failed — and what to do about it.
Human Genome Sciences, Inc. today announced that GlaxoSmithKline (GSK) has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval to market BENLYSTA® (belimumab) for the treatment of systemic lupus erythematosus (SLE).
Parents, caregivers and advocates joined hospital executives and legislators Tuesday to complain about the potential impact of [Louisiana] Gov. Bobby Jindal's proposed budget cuts and privatization initiatives on Louisiana's most vulnerable residents.
A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.
The International Coordinating Group on vaccine provision for yellow fever has provided 1.4 million vaccine doses for an immunization campaign that starts on Saturday (2 December) to help control an ongoing yellow fever outbreak in Nigeria.
› Verified 5 days ago
| Entity Name | Grow Healthcare Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245845932 PECOS PAC ID: 3476961368 Enrollment ID: O20220604000326 |
News Archive
Clinicians testing the drug dasatinib, approved for several blood cancers, had hoped it would slow the aggressive growth of the deadly brain cancer glioblastoma; however, clinical trials to date have not found any benefit. Researchers at Mayo Clinic, who conducted one of those clinical trials, believe they know why dasatinib failed — and what to do about it.
Human Genome Sciences, Inc. today announced that GlaxoSmithKline (GSK) has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval to market BENLYSTA® (belimumab) for the treatment of systemic lupus erythematosus (SLE).
Parents, caregivers and advocates joined hospital executives and legislators Tuesday to complain about the potential impact of [Louisiana] Gov. Bobby Jindal's proposed budget cuts and privatization initiatives on Louisiana's most vulnerable residents.
A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.
The International Coordinating Group on vaccine provision for yellow fever has provided 1.4 million vaccine doses for an immunization campaign that starts on Saturday (2 December) to help control an ongoing yellow fever outbreak in Nigeria.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Helen A Farrah-mcgrail, LISW 90 Hospital Dr, Athens, OH 45701-2301 Ph: (740) 593-3682 | Helen A Farrah-mcgrail, LISW 3194 Core Rd, Parkersburg, WV 26104-1556 Ph: (304) 485-5185 |
News Archive
Clinicians testing the drug dasatinib, approved for several blood cancers, had hoped it would slow the aggressive growth of the deadly brain cancer glioblastoma; however, clinical trials to date have not found any benefit. Researchers at Mayo Clinic, who conducted one of those clinical trials, believe they know why dasatinib failed — and what to do about it.
Human Genome Sciences, Inc. today announced that GlaxoSmithKline (GSK) has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval to market BENLYSTA® (belimumab) for the treatment of systemic lupus erythematosus (SLE).
Parents, caregivers and advocates joined hospital executives and legislators Tuesday to complain about the potential impact of [Louisiana] Gov. Bobby Jindal's proposed budget cuts and privatization initiatives on Louisiana's most vulnerable residents.
A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.
The International Coordinating Group on vaccine provision for yellow fever has provided 1.4 million vaccine doses for an immunization campaign that starts on Saturday (2 December) to help control an ongoing yellow fever outbreak in Nigeria.
› Verified 5 days ago
Mr. Joshua S. Watson, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2121 7th St, Parkersburg, WV 26101 Phone: 304-485-1721 Fax: 304-485-6710 | |
Patricia Vann, PHD, LPC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 7 Rosemar Cir, Parkersburg, WV 26104 Phone: 304-422-7999 Fax: 681-661-0257 | |
Jama J. Schott, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3194 Core Rd, Parkersburg, WV 26104 Phone: 304-485-5185 Fax: 304-485-0051 | |
Rachel A Scheiding, MSW, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2121 7th Street, Parkersburg, WV 26101 Phone: 304-485-1721 Fax: 304-424-9424 | |
Charmaine Y Dotson, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2801 Dudley Ave, Suite B, Parkersburg, WV 26101 Phone: 304-428-1114 Fax: 304-428-1135 | |
Mr. David M Schaffer, CSW, MSW, LICSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 3705 Emerson Ave, Parkersburg, WV 26104 Phone: 304-865-0272 Fax: 304-865-0265 | |
Marcia A Lang, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2121 7th St, Parkersburg, WV 26101 Phone: 304-485-1721 Fax: 304-485-9203 |